342 related articles for article (PubMed ID: 27806334)
21. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
22. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways.
Zhang Q; Tang X; Zhang ZF; Velikina R; Shi S; Le AD
Clin Cancer Res; 2007 Aug; 13(16):4686-94. PubMed ID: 17699846
[TBL] [Abstract][Full Text] [Related]
23. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF.
Song X; Wang L; Cai P; Xu Y; Liu Q; Fan D
Toxicol Appl Pharmacol; 2024 May; 486():116938. PubMed ID: 38642809
[TBL] [Abstract][Full Text] [Related]
24. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
25. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
Zhang J; Han L; Yu J; Li H; Li Q
Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
[TBL] [Abstract][Full Text] [Related]
26. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
Wu Z; Cai X; Huang C; Xu J; Liu A
Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract][Full Text] [Related]
28. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
29. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.
Jung JE; Kim HS; Lee CS; Park DH; Kim YN; Lee MJ; Lee JW; Park JW; Kim MS; Ye SK; Chung MH
Carcinogenesis; 2007 Aug; 28(8):1780-7. PubMed ID: 17557905
[TBL] [Abstract][Full Text] [Related]
30. Melittin inactivates YAP/HIF-1α pathway via up-regulation of LATS2 to inhibit hypoxia-induced proliferation, glycolysis and angiogenesis in NSCLC.
Li H
Clinics (Sao Paulo); 2024; 79():100407. PubMed ID: 38889502
[TBL] [Abstract][Full Text] [Related]
31. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
33. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
34. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.
Zhou F; Du J; Wang J
Mol Cell Biochem; 2017 Apr; 428(1-2):171-178. PubMed ID: 28063005
[TBL] [Abstract][Full Text] [Related]
35. Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer.
Mao G; Liu Y; Fang X; Liu Y; Fang L; Lin L; Liu X; Wang N
Angiogenesis; 2015 Jul; 18(3):373-82. PubMed ID: 26040900
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells.
Li G; He L; Zhang E; Shi J; Zhang Q; Le AD; Zhou K; Tang X
Cancer Lett; 2011 Dec; 311(2):160-70. PubMed ID: 21868151
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
38. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
[TBL] [Abstract][Full Text] [Related]
39. Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.
Lee JG; Wu R
Neoplasia; 2015 Feb; 17(2):190-200. PubMed ID: 25748238
[TBL] [Abstract][Full Text] [Related]
40. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
